PLX
Protalix Biotherapeutics
$2.40
+$0.03 (+1.27%)Jul 27, 2026
Key metrics
The numbers that frame PLX today
- Market cap
- $193.37M
- P/E (TTM)
- 12.6
- EV / FCF
- 12.3
- Gross margin
- 70%
- EV / Sales
- 2.1
- ROIC
- 44.5%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $1.41
- 52wk High
- $3.19
Growth
Revenue and earnings trend for PLX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about PLX
Is Protalix Biotherapeutics a good buy?
Yes. Protalix Biotherapeutics has excellent quality and strong momentum. Both signals support the setup. Growth looks excellent, which supports the long-term business case. We think Protalix Biotherapeutics is selling at a low price.
What is the market capitalization of PLX?
Protalix Biotherapeutics's market capitalization is $193.37M.
What is the P/E ratio for PLX stock?
Protalix Biotherapeutics's current P/E ratio is 12.6.
What is the 52-week high for PLX stock?
The 52-week high for Protalix Biotherapeutics is $3.19. The current close of $2.40 is 24.8% below that high.
What is the 52-week low for PLX stock?
The 52-week low for Protalix Biotherapeutics is $1.41. The current close of $2.40 is 70.2% above that low.
Does PLX stock pay dividends?
Protalix Biotherapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for PLX?
Protalix Biotherapeutics's Debt / Equity ratio is 0.13.